Lodaxaprine

Drug Profile

Lodaxaprine

Alternative Names: CM 40907

Latest Information Update: 04 Feb 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sanofi-Synthelabo
  • Class Antiepileptic drugs; Neuroprotectants; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Epilepsy

Most Recent Events

  • 19 Dec 1996 New profile
  • 19 Dec 1996 Discontinued-I for Epilepsy in Germany (PO)
  • 19 Dec 1996 Discontinued-II for Epilepsy in France (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top